CTT Pharmaceutical is trading at 0.049 as of the 12th of December 2024. This is a 2.97 percent decrease since the beginning of the trading day. The stock's open price was 0.0505. CTT Pharmaceutical has more than 64 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 12th of November 2024 and ending today, the 12th of December 2024. Click here to learn more.
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. Ctt Pharmaceutical is traded on OTC Exchange in the United States.. The company has 21.32 M outstanding shares. More on CTT Pharmaceutical Holdings
CTT Pharmaceutical Holdings [CTTH] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.17 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CTT Pharmaceutical's market, we take the total number of its shares issued and multiply it by CTT Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CTT Pharmaceutical conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 21.32 M outstanding shares.
CTT Pharmaceutical Holdings currently holds about 32.12 K in cash with (145.16 K) of positive cash flow from operations.
Check CTT Pharmaceutical Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in CTT Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Portfolio Dashboard Now
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
CTT Pharmaceutical financial ratios help investors to determine whether CTT Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CTT with respect to the benefits of owning CTT Pharmaceutical security.